Related Experiment Videos

Melorheostosis bone scintigraphy and F-18 fluorodeoxyglucose positron emission tomography

R T Kloos¹, P Shreve, L Fig

¹Department of Internal Medicine, University of Michigan, Ann Arbor, USA.

Clinical Nuclear Medicine

|October 1, 1996

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

No calcitonin change in a person taking dulaglutide diagnosed with pre-existing medullary thyroid cancer.

Diabetic medicine : a journal of the British Diabetic Association·2017

Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal.

The Journal of clinical endocrinology and metabolism·2009

Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.

The Journal of clinical endocrinology and metabolism·2005

Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC.

Histopathology·2004

Nasolacrimal obstruction secondary to I(131) therapy.

Ophthalmic plastic and reconstructive surgery·2004

Effects of dose, intervention time, and radionuclide on sodium iodide symporter (NIS)-targeted radionuclide therapy.

Gene therapy·2004

See all related articles